| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00322296 Details | 2013-04-16 Interventional | 2 | 8 | Bexarotene Parapsoriasis | The response rate (5/8) had reached a statistical significant endpoint. - | |||
| NCT00818090 Details | 2013-04-12 Interventional | 2 | 39 | Cisplatin Paclitaxel Carcinoma Thymoma Thymus Neoplasm… Thymic Carcinom… | marginal statistical significance - | |||
| NCT01135017 Details | 2013-04-11 Interventional | 4 | 112 | Dronedarone Atrial Fibrilla… | - Due to smaller-than-planned number of participants (112 instead of 424), results should be cautiously interpreted. However, the power to detect large treatment effect remained high and the posthoc power to detect a 60% reduction in AF burden was 99%. | |||
| NCT00828594 Details | 2013-04-11 Interventional | 1 | 130 | Everolimus Sorafenib Carcinoma Carcinoma, Hepa… Hepatocellular … | - - | |||
| NCT00369603 Details | 2013-04-11 Interventional | 4 | 4 | Donepezil Galantamine Alzheimer Disea… Alzheimer's Dis… | Reduced access to AchEI medication-naive mild AD patients. - | |||
| NCT00299611 Details | 2013-04-11 Interventional | 2/3 | 12 | Levetiracetam Sertraline Compulsive Pers… Obsessive-Compu… | Sponsor decided to terminate the study due to budget consideration - | |||
| NCT00054067 Details | 2013-04-11 Interventional | 3 | - | Cisplatin Uterine Cervica… Cervical Cancer | - - | |||
| NCT00033644 Details | 2013-04-11 Interventional | 2 | [1 Refs] | - | Dacarbazine Doxorubicin Liposomal doxor… Mitomycin Mitomycins Sargramostim Sarcoma | - - | ||
| NCT00030472 Details | 2013-04-11 Interventional | 2 | [1 Refs] | - | Doxorubicin Liposomal doxor… Uterine Cervica… Cervical Cancer | - - | ||
| NCT00023907 Details | 2013-04-11 Interventional | 2 | [1 Refs] | - | Paclitaxel Ovarian Cancer Primary Periton… | - - | ||
| NCT00016341 Details | 2013-04-11 Interventional | 3 | - | Doxorubicin Liposomal doxor… Megestrol Megestrol Aceta… Paclitaxel Tamoxifen Endometrial Neo… Endometrial Can… | - - | |||
| NCT00006812 Details | 2013-04-11 Interventional | 2 | [1 Refs] | - | Capecitabine Peritoneal Neop… Ovarian Cancer Primary Periton… | - - | ||
| NCT00006482 Details | 2013-04-11 Interventional | 2 | [1 Refs] | - | Gemcitabine Uterine Cervica… Cervical Cancer | - - | ||
| NCT00006224 Details | 2013-04-11 Interventional | 2 | [1 Refs] | - | Gemcitabine Uterine Cervica… Cervical Cancer | - - | ||
| NCT00004037 Details | 2013-04-11 Interventional | 2 | [1 Refs] | - | Docetaxel Carcinoma, Ovar… Ovarian Neoplas… Ovarian Cancer Primary Periton… | - - | ||
| NCT00003624 Details | 2013-04-11 Interventional | 2 | [1 Refs] | - | Amifostine Paclitaxel Endometrial Neo… Fallopian Tube … Neurotoxicity S… Sarcoma Uterine Cervica… Cervical Cancer Endometrial Can… Fallopian Tube … Neurotoxicity Ovarian Cancer Primary Periton… | - - | ||
| NCT00003386 Details | 2013-04-11 Interventional | 2 | - | BCG Vaccine Carboplatin Cyclophosphamid… Paclitaxel Vaccines Carcinoma, Ovar… Ovarian Cancer | - - | |||
| NCT00003316 Details | 2013-04-11 Interventional | 2 | [1 Refs] | - | Gemcitabine Sarcoma | - - | ||
| NCT00003156 Details | 2013-04-11 Interventional | 2 | [1 Refs] | - | Topotecan Carcinosarcoma Sarcoma | - - | ||
| NCT00002976 Details | 2013-04-11 Interventional | 3 | [1 Refs] | - | Estrogens Estrogens, Conj… Endometrial Neo… Endometrial Can… | - - |